Nyxoah

About:

Nyxoah is a medical device company focused on the development and commercialization of a hypoglossal nerve stimulation (HGNS) therapy.

Website: http://nyxoah.com

Twitter/X: nyxoah

Top Investors: European Investment Bank, ResMed, Gilde Healthcare, Cochlear, S.R.I.W.

Description:

Nyxoah is a health-technology company focused on the development and commercialization of innovative solutions and services to treat sleep disordered breathing conditions. Nyxoah's lead solution platform is based on the Genio® system, a validated, user-centered, next generation neurostimulation therapy for OSA, the world's most common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.